跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Retaclav-R - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Retaclav-R
Approved
STANDARD
Retaclav-R
Indchemie Health Specialities Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
395ee34177337344
Company
Indchemie Health Specialities Private Limited
Type
Standard
Approval Details
Approval Id
395ee34177337344
Drug Approval Philippines Name
Retaclav-R
Product Name
Retaclav-R
Registration Number
DRP-1093-09
Brand Name
Retaclav-R
Generic Name
Co-Amoxiclav
Dosage Form
Powder for Suspension
Dosage Strength
156.25 mg per 5 mL
Manufacturer
Indchemie Health Specialities Private Limited
Importer
Suhitas Pharmaceuticals Inc
Distributor
Reta Drug
Issuance Date
24 June 2024
Expiry Date
14 October 2028
Pharmacologic Category
Antibacterial (Penicillin)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
395ee34177337344
Type
Standard
Back to Philippines FDA Approvals